AEON Biopharma, Inc. (AEON)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
13,149,100
EV to revenue ratio (TTM)
201.68
EV to ebitda
-5.89
Financial Performance
Revenue (TTM)
0
Gross profit (TTM)
0
EBITDA
-19,818,000
Profitability
Operating margin (TTM)
0.00%
Profit margin
0.00%
Return on assets (TTM)
-141.50%
Return on equity (TTM)
0.00%
Per Share Metrics
Revenue per share (TTM)
0
EPS
-4.55
Diluted EPS (TTM)
-4.55
Book value
-0.58
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
1.158
PEG ratio
Price to sales ratio (TTM)
97.16
Price to book ratio (TTM)
Growth
Quarterly earnings growth (YoY)
0.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
0
Buy
3
Hold
0
Sell
0
Strong sell
0
Risk & Volatility
Beta
0.652